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DIACYLGLYCEROL ACYLTRANSFERASE 
SEQUENCES AND RELATED METHODS 
RELATED APPLICATIONS 
This application claims priority to US. Provisional Appli 
cation Ser. No. 61/116,195, ?led Nov. 19, 2008, and US. 
Provisional Application Ser. No. 61/149,896, ?led Feb. 4, 
2009, the entire disclosures of Which are incorporated herein 
by this reference. 
TECHNICAL FIELD 
The presently-disclosed subject matter relates to diacylg 
lycerol acyltransferase (DGAT) sequences and methods of 
using the same. In particular, the presently-disclosed subject 
matter relates to novel nucleic acid and amino acid sequences 
for DGAT and methods of using those sequences to increase 
the production of epoxy fatty acids. 
BACKGROUND 
Plant oil, largely in the form of triacylglycerol (TAG), is 
attractive as a reneWable resource to supplant or replace 
petroleum as a source of many compounds. Unlike most 
commercial oilseeds containing oil comprised predominantly 
of just ?ve main fatty acids, namely palmitic (C1610), stearic 
(C1810), oleic (C1811), linoleic (C1812) and ot-linolenic 
(C1813) acids, many exotic plant species have been found to 
contain high levels of unusual fatty acids, such as hydroxy, 
epoxy, and acetylenic fatty acids (van de Loo, et al., 1993). 
For example, an epoxy fatty acid, known as vernolic acid 
(cis-12-epoxyoctadeca-cis-9-enoic acid), can accumulate at 
levels up to 50-90% of the total fatty acids found in the seeds 
of Vernonia galamensis, Euphorbia lagascae, Slokesia lae 
vis, Crepispalaeslina, and Bernardiapulchella (Bafor, et al., 
1993; Pascual and Correal, 1992; Perdue, 1989; SpitZer, et al., 
1996; Thompson, et al., 1994). These unusual fatty acids have 
unique properties that make them valuable as reneWable raW 
materials for the chemical industry, and, in fact, many of these 
unusual fatty acids are used in making dyes, paints, coatings, 
adhesives, composites, plastics, and a variety of other prod 
ucts (JaWorski and Cahoon, 2003). HoWever, despite the 
value of these unusual fatty acids, the commercial production 
of the plants used to produce them has been signi?cantly 
hampered due to the poor agronomic properties of those 
plants, such as loW seed yields and loW seed retention, Which 
thus make the plants agronomically unsuited for industrial 
scale groWth and processing. 
Metabolic engineering of oilseeds provides a platform for 
the production of these unusual fatty acids. HoWever, recent 
efforts to express genes driving the synthesis of unusual fatty 
acids in commercial oil crops have been generally met With 
only limited success, With much loWer amounts of the desired 
fatty acid accumulating in the oils of transgenic plants as 
compared With the native plant species (Burgal, et al., 2008; 
Cahoon, et al., 2007; JaWorski and Cahoon, 2003; Singh, et 
al., 2005; Thelen and Ohlrogge, 2002). Indeed, the transgenes 
used in these previous attempts to synthesiZe unusual fatty 
acids have been mainly divergent members of the A12-oleic 
acid desaturase gene family, Which encode alternative enZy 
matic functions, such as epoxidation, hydroxylation, acety 
lenation, and conjugation, rather than the function of the 
typical fatty acid desaturase that catalyZes the introduction of 
a cis-A12 double bond in oleic acid (C1811) to form linoleic 
acid (C1812). As such, it is clear from these previous reports 
that for developing engineered oilseeds that accumulate 
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higher levels of industrially-important unusual fatty acids, 
additional genes are needed, including genes responsible for 
the ef?cient and selective ?ux of unusual fatty acids from the 
site of synthesis on phospho lipids to storage in TAGs. 
SUMMARY 
This summary describes several embodiments of the pres 
ently-disclosed subject matter, and, in many cases, lists varia 
tions and permutations of these embodiments. This Summary 
is merely exemplary of the numerous and varied embodi 
ments. Mention of one or more representative features of a 
given embodiment is likeWise exemplary. Such an embodi 
ment can typically exist With or Without the feature(s) men 
tioned; likeWise, those features can be applied to other 
embodiments of the presently-disclosed subject matter, 
Whether listed in this Summary or not. To avoid excessive 
repetition, this Summary does not list or suggest all possible 
combinations of such features. 
The presently-disclosed subject matter includes diacylg 
lycerol acyltransferase (DGAT) nucleic acid and amino acid 
sequences, as Well as methods of using those sequences to 
increase the production of epoxy fatty acids. 
In some embodiments of the presently-disclosed subject 
matter, an isolated nucleic acid sequence is provided that 
comprises a sequence of SEQ ID NO: 1. In some embodi 
ments, an isolated nucleic acid sequence is provided that 
encodes a polypeptide comprising an amino acid sequence of 
SEQ ID NO: 2. In some embodiments, the nucleic acid 
encodes a diacylglycerol acyltransferase 2 (DGAT2) 
polypeptide. In some embodiments, the isolated nucleic acid 
sequences of the presently-disclosed subject matter further 
comprise a sequence that selectively hybridiZes to the 
sequence of SEQ ID NO: 1 and, in some embodiments, that 
sequence is complementary to the sequence of SEQ ID NO: 1 . 
In some embodiments of the presently-disclosed subject 
matter, an isolated polypeptide is provided that comprises the 
sequence of SEQ ID NO: 2 or a sequence that is about 85% 
homologous to the sequence of SEQ ID NO: 2. In some 
embodiments, the polypeptide is encoded by a nucleic acid 
sequence comprising the sequence of SEQ ID NO: 1. In other 
embodiments, the polypeptide is encoded by a nucleic acid 
sequence that is complementary to a nucleic acid sequence 
that selectively hybridiZes to the sequence of SEQ ID NO: 1. 
In some embodiments, the polypeptide is a DGAT2 polypep 
tide 
Further provided, in some embodiments, are vectors that 
include a nucleic acid sequence of the presently-disclosed 
subject matter. In some embodiments, a vector is provided 
that comprises an isolated nucleic acid encoding polypeptide 
comprising an amino acid sequence of SEQ ID NO: 2. In 
some embodiments, a vector is provided Where the isolated 
nucleic acid is operably linked to an expression cassette, 
Which, in some embodiments, includes a seed-speci?c pro 
moter or a constitutive promoter. 
In some embodiments of the presently-disclosed subject 
matter, transgenic plant cells are provided. In some embodi 
ments, a transgenic plant cell is provided that comprises a 
vector that includes an isolated nucleic acid sequence that 
encodes a polypeptide comprising an amino acid sequence of 
SEQ ID NO: 2. In some embodiments, the transgenic plant 
cell comprises an isolated nucleic acid that is operably linked 
to an expression cassette, Which, in some embodiments, can 
further include a seed-speci?c or a constitutive promoter. 
Still further provided, in some embodiments of the pres 
ently-disclosed subject matter, are methods for producing an 
epoxy fatty acid. In some embodiments, a method of produc 
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ing an epoxy fatty acid is provided that comprises transform 
ing a cell With a ?rst isolated nucleic acid that encodes a 
diacylglycerol acyltransferase (DGAT) polypeptide and a 
second isolated nucleic acid that encodes an epoxygenase 
(EPX) polypeptide such that expression of the DGAT 
polypeptide and the EPX polypeptide increases an amount of 
epoxy fatty acid in the cell. In some embodiments, transform 
ing the cell With the ?rst isolated nucleic acid and the second 
isolated nucleic acid comprises transforming the cell With a 
vector that includes the ?rst isolated nucleic acid and a vector 
that includes the second isolated nucleic acid. In some 
embodiments, the ?rst isolated nucleic acid and the second 
isolated nucleic acid are each operatively linked to an expres 
sion cassette, Which, in some embodiments, includes a seed 
speci?c promoter or a constitutive promoter. 
In some embodiments of the presently-disclosed methods 
of producing an epoxy fatty acid, the DGAT polypeptide is a 
diacylglycerol acyltransferase l (DGATl) polypeptide. In 
some embodiments, the DGATl polypeptide is a diacylglyc 
erol acyltransferase la (DGATla) polypeptide, such as a 
DGATla polypeptide that is encoded by the nucleic acid 
sequence of SEQ ID NO: 4. In some embodiments, the 
DGATl polypeptide is a diacylglycerol acyltransferase lb 
(DGATlb) polypeptide, such as a DGATlb polypeptide that 
is encoded by the nucleic acid sequence of SEQ ID NO: 17. In 
other embodiments, the DGAT polypeptide is a DGAT2 
polypeptide, such as the DGAT2 polypeptide that is encoded 
by the nucleic acid sequence of SEQ ID NO: 1. In some 
embodiments, the epoxygenase polypeptide used in the pres 
ently-disclosed methods of producing an epoxy fatty acid is 
encoded by a nucleic acid sequence of SEQ ID NO: 5. 
In some embodiments of the presently-disclosed methods 
of producing an epoxy fatty acid, the epoxy fatty acid is 
vernolic acid. In some embodiments, the amount of vernolic 
acid produced in a cell by the presently-disclosed methods is 
about 14 percent to about 26 percent. 
Advantages of the presently-disclosed subject matter Will 
become evident to those of ordinary skill in the art after a 
study of the description, Figures, and non-limiting Examples 
in this document. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. 1A and 1B include schematic diagrams shoWing 
sequence analyses of the amino acid sequence of a diacylg 
lycerol acyltransferase 2 (DGAT2) polypeptide from Ver 
nonia galamensis (V gDGAT2: GENBANK® Accession No. 
EJ652577) in comparison With other DGAT2 polypeptides, 
including those from: Caenorhabdilis elegans (CeDGAT2A: 
GENBANK® Accession No. Z8l557; CeDGAT2B: GEN 
BANK® Accession No. U64852); Mus musculus (MmD 
GAT2: GENBANK® Accession No. AK002443); Morlier 
ella ramanniana (MrDGAT2A: GENBANK® Accession No. 
AF391089; MrDGAT2B: GENBANK® Accession No. 
AF39lO90); Saccharomyces cerevisiae (ScDGAT2: GEN 
BANK® Accession No. NCOOl 147); Arabidopsis Zhaliana 
(AtDGAT2: GENBANK® Accession No. NMl 1501 1.3); 
Verniciafordii (tung tree) (VfDGAT2: GENBANK® Acces 
sion No. ABC94473); Ricinus communis (castor) (RcD 
GAT2: GENBANK® Accession No. AY9l6l29); Trilicum 
aeslivum (Wheat) (TaDGAT2: GENBANK® Accession No. 
TC208469); Oryza saliva (rice) (OsDGAT2: GENBANK® 
Accession No. NPl057530.l); andBrassica napus (canola or 
rapeseed) (BnDGAT2: GENBANK® Accession No. 
AF155224). FIG. 1A is a schematic diagram shoWing the 
alignment of DGAT2 polypeptides from ?ve different plant 
species including VgDGAT2 (SEQ ID NO: 2); RcDGAT2 
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(SEQ ID NO: 13); VfDGAT2 (SEQ ID NO: 14); AtDGAT2 
(SEQ ID NO: 15); and OsDGAT2 (SEQ ID NO: 16) polypep 
tides, Where amino acids identical in all ?ve polypeptides are 
shaded in black, tWo predicted membrane spanning domains 
are underlined, and a C-terminal endoplasmic reticulum (ER) 
retrieval motif is boxed. FIG. 1B is a schematic diagram 
shoWing a phylogenetic analysis of various DGAT2 polypep 
tide sequences from plants, yeast, and animals, Where the 
units at the bottom of the neighbor joining tree indicate the 
number of substitution events and Where a Vernonia galamen 
sis diacylglycerol acyltransferase lb polypeptide (V gD 
GATl) (GENBANK® Accession No. EF653277) Was used 
as the outgroup for comparison. 
FIGS. 2A-2C are graphs shoWing the expression patterns 
ofVgDGAT genes in relation to Vernonia galamensis seed oil 
synthesis, including: a graph shoWing VgDGATla (VgD 
GATl) and VgDGAT2 gene expression in different organs of 
Vernonia galamensis (FIG. 2A); a graph shoWing 
VgDGATla (VgDGATl) and VgDGAT2 gene expression 
during seed development in Vernonia galamensis (FIG. 2B); 
and a graph shoWing the accumulation of vernolic acid (per 
cent of total fatty acid methyl esters) and total seed fatty acids 
(percent of dry Weight) in developing seeds of Vernonia gala 
mensis (FIG. 2C). 
FIGS. 3A-3B are images of agarose gels shoWing the 
expression of transgenes in agro-in?ltrated petunia leaves 
over time including: an image of a gel shoWing the time 
course of expression of a Stokesia laevis epoxygenase 
(SlEPX) transgene in agro-in?ltrated petunia leaves at 2, 3, 5, 
7, and 9 days after agro-in?ltration (FIG. 3A); and, an image 
of an agarose gel shoWing reverse-transcriptase polymerase 
chain reaction (RT-PCR) recovery of VgDGAT2 transcripts 
in agro-in?ltrated petunia leaves at l, 2, 3, 4, and 5 days after 
agro-in?ltration (FIG. 3B). 
FIGS. 4A and 4B are graphs shoWing fatty acid pro?les in 
agro-in?ltrated petunia leaves (FIG. 4A) expressing a SlEPX 
transgene (SlEPX) alone or in combination With a 
VgDGATla transgene (VgDGATl/SlEPX) or a VgDGAT2 
transgene (VgDGAT2/SlEPX), and shoWing vernolic acid 
and total lipid contents in triacyglycerols (Total TAG) 
extracted from the agro-in?ltrated petunia leaves (FIG. 4B). 
FIG. 5 is an image of an agarose gel shoWing a transcript 
analysis of transgenic soybean somatic embryos expressing 
either: a VgDGATla (V gDGATl) transgene and a SlEPX 
transgene (Lane 1); a VgDGAT2 transgene and a SlEPX 
transgene (lane 2); or a SlEPX transgene (Lane 3). Lanes 4 
and 5 included samples from a vector-control line and an 
untransformed line, respectively, and M indicates a DNA 
ladder. 
FIG. 6 is a graph shoWing vernolic acid contents of trans 
genic soybean seeds from regenerated plants expressing 
either: a SlEPX transgene (SlEPX); a VgDGATla transgene 
and a SlEPX transgene (VgDGATl/SlEPX); or a VgDGAT2 
transgene and a SlEPX transgene (V gDGAT2/ SlEPX). 
FIG. 7 includes a schematic diagram and a table shoWing 
the vernolic acid (Va) content in different sections of soybean 
seeds expressing a SlEPX transgene and a VgDGAT2 trans 
gene, Where the seeds Were divided into ?ve sections, as 
indicated, and each section Was analyZed for vernolic acid 
content. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is a nucleic acid sequence of the open 
reading frame (ORF) of a diacylglycerol acyltransferase 2 
(DGAT2) gene from Vernonia galamensis. 
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SEQ ID NO: 2 is an amino acid sequence of a DGAT2 
polypeptide from Vernonia galamensis. 
SEQ ID NO: 3 is a nucleic acid sequence of a full-length 
DGAT2 gene from Vernonia galamensis. 
SEQ ID NO: 4 is a nucleic acid sequence of a diacylglyc 
erol acyltransferase 1a (DGAT1a) cDNA obtained from Ver 
nonia galamensis. 
SEQ ID NO: 5 is a nucleic acid sequence of an epoxyge 
nase cDNA obtained from Slokesia laevis. 
SEQ ID NO: 6 is an amino acid sequence of an endoplas 
mic reticulum (ER) retrieval motif of a Vernonia galamensis 
DGAT2 protein. 
SEQ ID NO: 7 is a nucleic acid sequence of a forWard 
primer for amplifying Vernonia galamensis DGAT1a cDNA. 
SEQ ID NO: 8 is a nucleic acid sequence of a reverse 
primer for amplifying Vernonia galamensis DGAT1a cDNA. 
SEQ ID NO: 9 is a nucleic acid sequence of a forWard 
primer for amplifying Vernonia galamensis DGAT2 cDNA. 
SEQ ID NO: 10 is a nucleic acid sequence of a reverse 
primer for amplifying Vernonia galamensis DGAT2 cDNA. 
SEQ ID NO: 11 is a nucleic acid sequence of a forWard 
primer for amplifying a portion of an actin gene. 
SEQ ID NO: 12 is a nucleic acid sequence of a reverse 
primer for amplifying a portion of an actin gene. 
SEQ ID NO: 13 is an amino acid sequence of a DGAT2 
polypeptide from Ricinus communis (castor). 
SEQ ID NO: 14 is an amino acid sequence of a DGAT2 
polypeptide from Verniciafordii (tung tree). 
SEQ ID NO: 15 is an amino acid sequence of a DGAT2 
polypeptide from Arabidopsis Zhaliana. 
SEQ ID NO: 16 is an amino acid sequence of a DGAT2 
polypeptide from Oryza satvia (rice). 
SEQ ID NO: 17 is a nucleic acid sequence of a diacylglyc 
erol acyltransferase lb (DGAT1b) cDNA obtained from Ver 
nonia galamensis. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently 
disclosed subject matter are set forth in this document. Modi 
?cations to embodiments described in this document, and 
other embodiments, Will be evident to those of ordinary skill 
in the art after a study of the information provided in this 
document. The information provided in this document, and 
particularly the speci?c details of the described exemplary 
embodiments, is provided primarily for cleamess of under 
standing and no unnecessary limitations are to be understood 
therefrom. In case of con?ict, the speci?cation of this docu 
ment, including de?nitions, Will control. 
Some of the polynucleotide and polypeptide sequences 
disclosed herein are cross-referenced to GENBANK® acces 
sion numbers. The sequences cross-referenced in the GEN 
BANK® database are expressly incorporated by reference as 
are equivalent and related sequences present in GENBANK® 
or other public databases. Also expressly incorporated herein 
by reference are all annotations present in the GENBANK® 
database associated With the sequences disclosed herein. 
Unless otherWise indicated or apparent, the references to the 
GENBANK® database are references to the mo st recent ver 
sion of the database as of the ?ling date of this Application. 
While the terms used herein are believed to be Well-under 
stood by one of ordinary skill in the art, de?nitions are set 
forth to facilitate explanation of the presently-disclosed sub 
ject matter. 
Unless de?ned otherWise, all technical and scienti?c terms 
used herein have the same meaning as commonly understood 
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by one of ordinary skill in the art to Which the presently 
disclosed subject matter belongs. Although any methods, 
devices, and materials similar or equivalent to those described 
herein can be used in the practice or testing of the presently 
disclosed subject matter, representative methods, devices, 
and materials are noW described. 
Following long-standing patent laW convention, the terms 
“a,” “an,” and “the” refer to “one or more” When used in this 
application, including the claims. Thus, for example, refer 
ence to “a cell” includes a plurality of such cells, and so forth. 
Unless otherWise indicated, all numbers expressing quan 
tities of ingredients, properties such as reaction conditions, 
and so forth used in the speci?cation and claims are to be 
understood as being modi?ed in all instances by the term 
“about.” Accordingly, unless indicated to the contrary, the 
numerical parameters set forth in this speci?cation and claims 
are approximations that can vary depending upon the desired 
properties sought to be obtained by the presently-disclosed 
subject matter. 
As used herein, the term “about,” When referring to a value 
or to an amount of mass, Weight, time, volume, concentration 
or percentage is meant to encompass variations of in some 
embodiments:20%, in some embodiments:10%, in some 
embodiments:5%, in some embodiments:1%, in some 
embodiments:0.5%, and in some embodiments:0.1% from 
the speci?ed amount, as such variations are appropriate to 
perform the disclosed method. 
The production of seed oils in plants typically involves de 
novo fatty acid synthesis in plastids, fatty acid modi?cation 
by membrane-bound enZymes in the endoplasmic reticulum 
(ER), fatty acid incorporation into triacylglycerol (TAG), and 
subsequent accumulation in oil bodies that bud off from the 
ER. In this regard, unusual fatty acids, such as hydroxyl, 
epoxy, and acetylenic fatty acids, are often ?rst formed on 
phosphatidylcholine (PC) in the ER though the modi?cation 
of oleic (C1 8:1) or linoleic (C1812) acids by fatty acid desatu 
rase 2 (FAD2)-like enZymes or by cytochrome P-450s. 
Regardless of the particular synthesis mechanism for the fatty 
acid, hoWever, in the ER, the sequential incorporation of fatty 
acids onto TAG is commonly knoWn as the Kennedy pathWay, 
Which consists of three successive acylation reactions of the 
hydroxyl groups of glycerol by three acyl-CoA-dependent 
acyltransferases, starting from glycerol-3-phosphate (G3P). 
Speci?cally, in the Kennedy pathWay, lysophosphatidic acid 
(LPA) and phosphatidic acid (PA) are ?rst formed through 
tWo acylations catalyZed by the acyltransferases glycerol-3 
phosphate (GPAT) and lyso-phosphatidic acid acyltrans 
ferase (LPAAT). PA is then dephosphorylated by the action of 
phosphatidate phosphatase (PAP) to form sn-1,2-diacylglyc 
erol(sn-1,2 DAG). The ?nal acylation of sn-1,2 DAG is the 
transfer of a fatty acyl moiety, such as from acyl-CoA, to the 
sn-3 position of diacylglycerol by diacylglycerol acyltrans 
ferase (DGAT) to generate TAG. 
It is thought that DGAT is one of the rate-limiting steps in 
plant storage lipid accumulation and plays a role in control 
ling both the quantitative and qualitative ?ux of fatty acids 
into storage TAGs. There are tWo distinct types of non-ho 
mologous DGAT gene families designated as DGAT1 and 
DGAT2 encoding proteins With DGAT activity in plants 
(LardiZabal, et al. 2001; Shockey, et al. 2006) and animals 
(Cases, et al. 2001). Furthermore, in certain species, such as 
soybean, Vernonia galamensis, and Euphorbia species, 
DGAT1 genes can further be divided into tWo distinct sub 
classes, designated DGAT1a and DGAT1b. Recently, the spe 
ci?c functions of both DGAT1 and DGAT2 in the high accu 
mulation of unusual fatty acids, such as epoxy and hydroxy 
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fatty acids, in seed oils are beginning to be determined (see, 
e.g., He, et al. 2004; Kroon, et al. 2006; Shocky, et al. 2006; 
Burgal, et al. 2008). 
For industrial applications, however, epoxy fatty acids are 
still currently produced by chemical epoxygenation of the 
carbon double bonds present in highly unsaturated vegetable 
oils, such as soybean and linseed oils, or by synthesis from 
petrochemicals. As such, it Would be desirable, both from an 
economic and environmental standpoint, to transfer the syn 
thesis pathWay of epoxy fatty acids from the Wild plant spe 
cies into oil crops by metabolic engineering, as many of the 
Wild plant species are not suited for the industrial scale 
groWth and processing that is commonly seen in many oil 
seed crops. 
Disclosed herein are data demonstrating that DGAT 
nucleic acid and amino acids sequences can be used to affect 
a change in the accumulation of epoxy fatty acids in cells. As 
disclosed herein, DGAT proteins Were expressed in cells of 
various plant species in combination With an epoxygenase 
protein, and it Was ascertained that the co-expression of these 
proteins resulted in an increase of total epoxy fatty acid levels, 
including levels of vemolic acid, in these cells. To that end, 
the presently-disclosed subject matter includes isolated 
DGAT nucleotide and amino acid sequences, as Well as meth 
ods of using these sequences to increase the amounts of epoxy 
fatty acids in cells. 
In some embodiments of the presently-disclosed subject 
matter, isolated nucleic acids are provided. In some embodi 
ments, an isolated nucleic acid is provided that comprises a 
sequence of SEQ ID NO: 1. In some embodiments, an iso 
lated nucleic acid is provided that is isolated from Vernonia 
galamensis. In some embodiments, an isolated nucleic acid is 
provided that is isolated from a DGAT2 gene that encodes a 
Vernonia galamensis DGAT2 polypeptide. 
The term “gene” is used broadly to refer to any segment of 
DNA associated With a biological function. Thus, genes 
include, but are not limited to, coding sequences and/or the 
regulatory sequences required for their expression. Genes can 
also include non-expressed DNA segments that, for example, 
form recognition sequences for a polypeptide. Genes can be 
obtained from a variety of sources, including cloning from a 
source of interest or synthesizing from known or predicted 
sequence information, and can include sequences designed to 
have desired parameters. 
The term “nucleic acid” refers to deoxyribonucleotides or 
ribonucleotides and polymers thereof in either single- or 
double-stranded form. Unless speci?cally limited, the term 
encompasses nucleic acids containing knoWn analogues of 
natural nucleotides that have similar binding properties as the 
reference nucleic acid and are metabolized in a manner simi 
lar to naturally-occurring nucleotides. Unless otherWise indi 
cated, a particular nucleic acid sequence also implicitly 
encompasses conservatively modi?ed or degenerate variants 
thereof (e.g., degenerate codon substitutions) and comple 
mentary sequences, as Well as the sequence explicitly indi 
cated. 
The term “isolated,” When used in the context of an isolated 
nucleic acid or an isolated polypeptide, is a nucleic acid or 
polypeptide that, by the hand of man, exists apart from its 
native environment and is therefore not a product of nature. 
An isolated nucleic acid or polypeptide can exist in a puri?ed 
form or can exist in a non-native environment such as, for 
example, in a transgenic host cell. 
The term “degenerate variant” refers to a nucleic acid hav 
ing a residue sequence that differs from a reference nucleic 
acid by one or more degenerate codon substitutions. Degen 
erate codon substitutions can be achieved by generating 
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sequences in Which the third position of one or more selected 
(or all) codons is substituted With mixed base and/or deoxyino 
sine residues (Batzer, et al. 1991; Ohtsuka, et al. 1985; Ros 
solini, et al. 1994). 
In some embodiments, an isolated nucleic acid sequence is 
provided that selectively hybridizes to the sequence of SEQ 
ID NO: 1. The term “selectively hybridize” as used herein 
refers to the ability of a nucleic acid sequence to hybridize to 
a target polynucleotide (e.g., a polynucleotide of SEQ ID NO: 
1) With speci?city. Thus, the nucleic acid sequence comprises 
a polynucleotide sequence that is complementary, or essen 
tially complementary, to at least a portion of the target poly 
nucleotide sequence. For example, in some embodiments, the 
nucleic acid sequence that selectively hybridizes to the 
sequence of SEQ ID NO: 1 is complementary to the sequence 
of SEQ ID NO: 1. Nucleic acid sequences Which are “comple 
mentary” are those Which are base-pairing according to the 
standard Watson-Crick complementarity rules. As used 
herein, the term “complementary sequences” means nucleic 
acid sequences Which are substantially complementary, as 
can be assessed by the same nucleotide comparison set forth 
above, or as de?ned as being capable of hybridizing to the 
nucleic acid segment in question under relatively stringent 
conditions such as those described herein. A particular 
example of a contemplated complementary nucleic acid seg 
ment is an antisense oligonucleotide. With regard to the 
nucleic acid sequences disclosed herein as selectively hybrid 
izing to the sequence of SEQ ID NO: 1, the hybridizing 
nucleic acid sequence need not necessarily be completely 
complementary to the nucleic acid of SEQ ID NO: 1 along the 
entire length of the target polynucleotide so long as the 
hybridizing nucleic acid sequence can bind the nucleic acid of 
SEQ ID NO: 1 With speci?city. In some embodiments, the 
nucleic acid sequences that selectively hybridize to the 
sequence of SEQ ID NO: 1 are about 80%, about 85%, about 
90%, about 95%, about 98%, or about 100% complementary 
to the sequence of SEQ ID NO: 1. 
Nucleic acid hybridization Will be affected by such condi 
tions as salt concentration, temperature, or organic solvents, 
in addition to the base composition, length of the complemen 
tary strands, and the number of nucleotide base mismatches 
betWeen the hybridizing nucleic acids, as Will be readily 
appreciated by those skilled in the art. Stringent temperature 
conditions Will generally include temperatures in excess of 
300 C., typically in excess of 37° C., and preferably in excess 
of 45° C. Stringent salt conditions Will ordinarily be less than 
1,000 mM, typically less than 500 mM, and preferably less 
than 200 mM. For example, in some embodiments, nucleic 
acid hybridization can be performed at 600 C. with 01x 
sodium citrate-sodium chloride (SSC) and 0.1% sodium 
dodecyl sulfate (SDS). HoWever, the combination of param 
eters is much more important than the measure of any single 
parameter. (See, e. g., Wetmur & Davidson, 1968). Determin 
ing appropriate hybridization conditions to identify and/or 
isolate sequences containing high levels of homology is Well 
knoWn in the art. (See, e.g., Sambrook, et al., 1989). 
In some embodiments of the presently-disclosed subject 
matter, an isolated nucleic acid is provided that encodes a 
polypeptide comprising an amino acid sequence of SEQ ID 
NO: 2. In some embodiments, an isolated nucleic acid 
sequence is provided that encodes a DGAT2 polypeptide, 
such as a DGAT2 polypeptide isolated from Vernonia gala 
mensis. 
The terms “polypeptide, protein,” and “peptide,” Which 
are used interchangeably herein, refer to a polymer of the 20 
protein amino acids, or amino acid analogs, regardless of its 
size or function. Although “protein” is often used in reference 
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to relatively large polypeptides, and “peptide” is often used in 
reference to small polypeptides, usage of these terms in the art 
overlaps and varies. The term “polypeptide” as used herein 
refers to peptides, polypeptides, and proteins, unless other 
Wise noted. The terms “protein”, “polypeptide” and “peptide” 
are used interchangeably herein When referring to a gene 
product. Thus, exemplary polypeptides include gene prod 
ucts, naturally occurring proteins, homologs, orthologs, para 
logs, fragments and other equivalents, variants, and analogs 
of the foregoing. 
The terms “polypeptide fragment” or “fragment,” When 
used in reference to a reference polypeptide, refers to a 
polypeptide in Which amino acid residues are deleted as com 
pared to the reference polypeptide itself, but Where the 
remaining amino acid sequence is usually identical to the 
corresponding positions in the reference polypeptide. Such 
deletions can occur at the amino-terminus or carboxy-termi 
nus of the reference polypeptide, or alternatively both. 
A fragment can also be a “functional fragment,” in Which 
case the fragment retains some or all of the activity of the 
reference polypeptide as described herein. For example, in 
some embodiments, a functional fragment of a DGAT2 
polypeptide can retain some or all of the ability of the refer 
ence polypeptide to catalyZe the ?nal acylation step during 
TAG synthesis, such as What had been described for DGATl 
polypeptides (see, e.g., Siloto, et al., 2009; Siloto, et al., 2009; 
and Xu, et al. 2008). 
The terms “modi?ed amino acid,” “modi?ed polypeptide,” 
and “variant” refer to an amino acid sequence that is different 
from the reference polypeptide by one or more amino acids, 
e.g., one or more amino acid substitutions. A variant of a 
reference polypeptide also refers to a variant of a fragment of 
the reference polypeptide, for example, a fragment Wherein 
one or more amino acid substitutions have been made relative 
to the reference polypeptide. A variant can also be a “func 
tional variant,” in Which the variant retains some or all of the 
activity of the reference protein as described herein. For 
example, a functional variant of a DGAT2 polypeptide retains 
some or all of the ability of the reference polypeptide to 
catalyZe the ?nal acylation step during TAG synthesis. 
The term functional variant also includes a functional vari 
ant of a functional fragment of a reference polypeptide. The 
term functional variant further includes conservatively sub 
stituted variants. The term “conservatively substituted vari 
ant” refers to a peptide comprising an amino acid residue 
sequence that differs from a reference peptide by one or more 
conservative amino acid substitutions, and maintains some or 
all of the activity of the reference peptide as described herein. 
A “conservative amino acid substitution” is a substitution of 
an amino acid residue With a functionally similar residue. 
Examples of conservative substitutions include the substitu 
tion of one non-polar (hydrophobic) residue such as isoleu 
cine, valine, leucine or methionine for another; the substitu 
tion of one charged or polar (hydrophilic) residue for another 
such as betWeen arginine and lysine, betWeen glutamine and 
asparagine, betWeen threonine and serine; the substitution of 
one basic residue such as lysine or arginine for another; or the 
substitution of one acidic residue, such as aspartic acid or 
glutamic acid for another; or the substitution of one aromatic 
residue, such as phenylalanine, tyrosine, or tryptophan for 
another. The phrase “conservatively substituted variant” also 
includes peptides Wherein a residue is replaced With a chemi 
cally-derivatiZed residue, provided that the resulting peptide 
maintains some or all of the activity of the reference peptide 
as described herein. 
Further provided in some embodiments of the presently 
disclosed subject matter are isolated polypeptides. In some 
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embodiments, an isolated polypeptide is provided that com 
prises a sequence of SEQ ID NO: 2 ora sequence that is about 
85% homologous to SEQ ID NO: 2. The terms “homolo 
gous,” “homology,” or “percent homology” When used herein 
to describe to an amino acid sequence or a nucleic acid 
sequence, relative to a reference sequence, can be determined 
using the formula described by Karlin and Altschul (Proc. 
Natl. Acad. Sci. USA 87: 2264-2268, 1990, modi?ed as in 
Proc. Natl. Acad. Sci. USA 90:5873-5877, 1993). Such a 
formula is incorporated into the basic local alignment search 
tool (BLAST) programs ofAltschul et al. (J. Mol. Biol. 215: 
403-410, 1990). Percent homology of sequences canbe deter 
mined using the most recent version of BLAST, as of the 
?ling date of this application. 
In some embodiments, an isolated polypeptide is provided 
that is encoded by a nucleic acid sequence comprising the 
sequence of SEQ ID NO: 1. In some embodiments, the iso 
lated polypeptide is encoded by a nucleic acid sequence that 
is complementary to a nucleic acid sequence that selectively 
hybridiZes to the sequence of SEQ ID NO: 1 . In some embodi 
ments, the polypeptide is a DGAT2 polypeptide, such as a 
Vernonia galamensis DGAT2 polypeptide. 
Vernonia galamensis is a plant in the sun?oWer family of 
signi?cant industrial value due to high levels of vernolic acid, 
an epoxy fatty acid, found Within the seeds of the plant. 
Indeed, Vernonia galamensis is commonly groWn as a source 
of vernolic acid, Which is then used in a variety of industrial 
applications, such as the manufacture of plastics or paints. 
HoWever, the large-scale farming of Vernonia galamensis is 
typically not economically feasible, particularly outside of 
equatorial regions, due to poor seed yield and poor seed 
retention, Which thus makes the plants agronomically 
unsuited for the industrial scale groWth and processing that 
Would be required to make use of Vernonia galamensis plants 
as a viable source of epoxy fatty acids. Disclosed herein, 
hoWever, are data indicating the DGAT genes from Vernonia 
galamensis, such as Vernonia galamensis DGAT2 genes, can 
be inserted into a vector and then e?iciently and economically 
used to produce DGAT polypeptides that, in combination 
With an epoxygenase polypeptide, are capable of increasing 
the production of epoxy fatty acids in plants that can be groWn 
on a commercial scale. 
In some embodiments of the presently-disclosed subject 
matter, vectors that include one or more of the isolated nucleic 
acid sequences disclosed herein are provided. In some 
embodiments, a vector is provided that includes an isolated 
nucleic acid comprising a sequence of SEQ ID NO: 1. In some 
embodiments, a vector is provided that includes an isolated 
nucleic acid sequence that encodes a polypeptide comprising 
an amino acid sequence of SEQ ID NO: 2. 
The term “vector” is used herein to refer to any vehicle that 
is capable of transferring a nucleic acid sequence into another 
cell. For example, vectors Which may be used in accordance 
With the presently-disclosed subject matter include, but are 
not limited to, plasmids, cosmids, bacteriophages, or viruses, 
Which can be transformed by the introduction of a nucleic 
acid sequence of the presently-disclosed subject matter. Such 
vectors are Well knoWn to those of ordinary skill in the art. In 
some embodiments, the vectors of the presently-disclosed 
subject matter are plasmids, such as the plasmid pBIl2l or 
the pCAMBIAl30l plasmid. 
In some embodiments, the isolated nucleic acid included in 
the vector is operably linked to an expression cassette. The 
terms “associated Wit ,” “operably linked,” and “operatively 
linked” refer to tWo nucleic acid sequences that are related 
physically or functionally. For example, a promoter or regu 
latory DNA sequence is said to be “associated With” a DNA 
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sequence that encodes an RNA or a polypeptide if the tWo 
sequences are operatively linked, or situated such that the 
regulator DNA sequence Will affect the expression level of the 
coding or structural DNA sequence. 
The term “expression cassette” refers to a nucleic acid 
molecule capable of directing expression of a particular 
nucleotide sequence in an appropriate host cell, comprising a 
promoter operatively linked to the nucleotide sequence of 
interest Which is operatively linked to termination signals. It 
also typically comprises sequences required for proper trans 
lation of the nucleotide sequence. The coding region usually 
encodes a polypeptide of interest but can also encode a func 
tional RNA of interest, for example antisense RNA or a non 
translated RNA, in the sense or antisense direction. The 
expression cassette comprising the nucleotide sequence of 
interest can be chimeric, meaning that at least one of its 
components is heterologous With respect to at least one of its 
other components. The expression cassette can also be one 
that is naturally occurring but has been obtained in a recom 
binant form useful for heterologous expression. 
In some embodiments, an expression cassette is provided 
that comprises a “constitutive promoter,” such as a 35S pro 
moter, a ?gWort mosaic promoter, or the constitutive plant 
promoter of ubiquitin, that continually expresses a nucleic 
acid sequence of the presently-disclosed subject matter in all 
types of cells Where it is inserted. For some applications, it is 
useful to direct the expression of a nucleic acid sequence of 
the presently-disclosed subject matter to different tissues of a 
plant. As such, in some embodiments, an expression cassette 
is provided that comprises a “seed-speci?c promoter,” such as 
a phaseolin, glycinin, conglycinin, seed lectin, napin, 
cruferin, or other seed-speci?c promoter that expresses a 
nucleic acid sequence of the presently-disclosed subject mat 
ter only in seeds of a desired plant. 
The presently-disclosed subject matter also provides trans 
genic plant cells or plants that have been transformed With 
one or more of the vectors disclosed herein. As used herein, 
the term “plant cell” is understood to mean any cell derived 
from a monocotyledonous or a dicotyledonous plant and 
capable of constituting undifferentiated tissues such as calli, 
differentiated tissues such as embryos, portions of monocoty 
ledonous plants, monocotyledonous plants or seed. The term 
“plant” is understood to mean any differentiated multi-cellu 
lar organism capable of photosynthesis, including monocoty 
ledons and dicotyledons. In some embodiments, the plant cell 
can be an Arabidopsis plant cell, a tobacco plant cell, a soy 
bean plant cell, a petunia plant cell, or a cell from another 
oilseed crop including, but not limited to, a canola plant cell, 
a rapeseed plant cell, a palm plant cell, a sun?oWer plant cell, 
a cotton plant cell, a corn plant cell, a peanut plant cell, a ?ax 
plant cell, and a sesame plant cell. 
The terms “transformed,” “transgenic,” and “recombinant” 
are used herein to refer to a cell of a host organism, such as a 
plant, into Which a heterologous nucleic acid molecule has 
been introduced. The nucleic acid molecule can be stably 
integrated into the genome of the cell or the nucleic acid 
molecule can also be present as an extrachromosomal mol 
ecule. Such an extrachromosomal molecule can be auto-rep 
licating. Transformed cells, tissues, or subjects are under 
stood to encompass not only the end product of a 
transformation process, but also transgenic progeny thereof. 
The terms “heterologous,” “recombinant,” and “exog 
enous,” When used herein to refer to a nucleic acid sequence 
(e.g., a DNA sequence) or a gene, refer to a sequence that 
originates from a source foreign to the particular host cell or, 
if from the same source, is modi?ed from its original form. 
Thus, a heterologous gene in a host cell includes a gene that is 
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endogenous to the particular host cell but has been modi?ed 
through, for example, the use of site-directed mutagenesis or 
other recombinant techniques. The terms also include non 
naturally occurring multiple copies of a naturally occurring 
DNA sequence. Thus, the terms refer to a DNA segment that 
is foreign or heterologous to the cell, or homologous to the 
cell but in a position or form Within the host cell in Which the 
element is not ordinarily found. Similarly, When used in the 
context of a polypeptide or amino acid sequence, an exog 
enous polypeptide or amino acid sequence is a polypeptide or 
amino acid sequence that originates from a source foreign to 
the particular host cell or, if from the same source, is modi?ed 
from its original form. Thus, exogenous DNA segments can 
be expressed to yield exogenous polypeptides. 
Introduction of a nucleic acid (e. g., a nucleic acid incorpo 
rated into an appropriate vector) of the presently-disclosed 
subject matter into a plant cell can be performed by a variety 
of methods knoWn to those of ordinary skill in the art includ 
ing, but not limited to, insertion of a nucleic acid sequence of 
interest into an Agrobaclerium rhizogenes Ri or Agrobacle 
rium Zumefaciens Ti plasmid, microinj ection, electropora 
tion, or direct precipitation. By Way of providing an example, 
in some embodiments, transient expression of a nucleic acid 
sequence or gene of interest can be performed by agro-in?l 
tration methods. In this regard, a suspension of Agrobacle 
rium Zumefaciens containing a nucleic acid sequence or gene 
of interest can be groWn in culture and then injected into a 
plant by placing the tip of a syringe against the underside of a 
leaf While gentle counter-pressure is applied to the other side 
of the leaf The Agrobaclerium solution is then injected into 
the airspaces inside the leaf through stomata. Once inside the 
leaf, the Agrobacterium transforms the gene of interest to a 
portion of the plant cells Where the gene is then transiently 
expressed. 
As another example, transformation of a plasmid or nucleic 
acid of interest into a plant cell can be performed by particle 
gun bombardment techniques. In this regard, a suspension of 
plant embryos can be groWn in liquid culture and then bom 
barded With plasmids or nucleic acids that are attached to gold 
particles, Wherein the gold particles bound to the plasmid or 
nucleic acid of interest can be propelled through the mem 
branes of the plant tissues, such as embryonic tissue. FolloW 
ing bombardment, the transformed embryos can then be 
selected using an appropriate antibiotic to generate neW, 
clonally propagated, transformed embryogenic suspension 
cultures. 
For additional guidance regarding methods of transform 
ing and producing transgenic plant cells, see US. Pat. Nos. 
4,459,355; 4,536,475; 5,464,763; 5,177,010; 5,187,073; 
4,945,050; 5,036,006; 5,100,792; 5,371,014; 5,478,744; 
5,179,022; 5,565,346; 5,484,956; 5,508,468; 5,538,877; 
5,554,798; 5,489,520; 5,510,318; 5,204,253; 5,405,765; EP 
Nos. 267,159; 604,662; 672,752; 442,174; 486,233; 486,234; 
539,563; 674,725; and, International Patent Application Pub 
lication Nos. WO 91/02071 and WO 95/06128, each ofWhich 
is incorporated herein by this reference. 
Still further provided, in some embodiments of the pres 
ently-disclosed subject matter, are methods of producing an 
epoxy fatty acid. The term “epoxy fatty acids” is used herein 
to refer to an acyl chain of a fatty acidthat contains an epoxide 
bridge (i.e., an oxygen atom covalently bound to carbon 
atoms that are in turn covalently bound to each other to form 
a three-member ring that is part of a larger molecular struc 
ture). In plants, the biochemical reaction responsible for the 
production of epoxy fatty acid is often catalyZed by an epoxy 
genase enZyme, Which is capable of combining common fatty 
acids With oxygen to form epoxy fatty acids (see, e.g., U.S. 
US 8,431,772 B1 
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Pat. No. 7,364,901, Which is incorporated herein by this ref 
erence). For example, an epoxygenase catalyzes the conver 
sion of linoleic acid into the epoxy fatty acid vernolic acid 
(cis-12-epoxyoctadeca-cis-9-enoic acid). It has been deter 
mined, hoWever, that by co-expressing a nucleic acid encod 
ing an epoxygenase polypeptide With a nucleic acid encoding 
a DGAT polypeptide in plant cells, the levels of epoxy fatty 
acids, such as vernolic acid, can be signi?cantly increased in 
the plant cells as compared to Wild-type plant cells or plant 
cells expressing DGAT genes or epoxygenase genes by them 
selves 
In some embodiments of the presently-disclosed methods, 
a method of producing an epoxy fatty acid is provided that 
comprises transforming a cell With a ?rst nucleic acid that 
encodes a DGAT polypeptide and a second isolated nucleic 
acid that encodes an epoxygenase polypeptide such that the 
expression of the DGAT polypeptide and the epoxygenase 
polypeptide increases an amount of epoxy fatty acid in the 
cell. In some embodiments of the presently-disclosed subject 
matter, the epoxy fatty acid is vernolic acid 
The “amount” of an epoxy fatty acid in a cell can be 
determined by methods knoWn to those of ordinary skill in the 
art. For example, gas chromatography-mass spectrometry, 
thin layer chromatography-gas chromatography, or gas chro 
matography can be utilized to determine a total amount of 
epoxy fatty acids or an amount of a particular epoxy fatty 
acid, such as vernolic acid, in a sample obtained from a cell 
transformed With a nucleic acid of the presently-disclosed 
subject matter. An increase in the amount of an epoxy fatty 
acid can then be measured relative to a control level of the 
epoxy fatty acid, such as an amount or range of amounts of the 
epoxy fatty acid found in a comparable samples in cells that 
have not been transformed With a nucleic acid of the pres 
ently-disclosed subject matter. In some embodiments, the 
increase in the amounts of an epoxy fatty acid can be about 
1%, about 5%, about 10%, about 15%, about 20%, about 
25%, about 30%, about 40%, about 45%, or about 50%. In 
some embodiments, the increase in the amounts of an epoxy 
fatty acid is about 14% to about 26%. 
In some embodiments of the methods for producing an 
epoxy fatty acid, transforming the cell With the ?rst isolated 
nucleic acid and the second isolated nucleic acid comprises 
transforming the cell With a vector that includes the ?rst 
isolated nucleic acid and a vector that includes the second 
isolated nucleic acid. For example, in some embodiments, a 
nucleic acid encoding a DGAT polypeptide can be inserted 
into an appropriate vector as described herein and a nucleic 
acid encoding an epoxygenase polypeptide can be inserted 
into another vector. In some embodiments, each of the vectors 
can then be electroporated into Agrobaclerium Zumefacians 
cells, Which can then be used to transform cells With the 
vectors according to agro-in?ltration methods knoWn to those 
of ordinary skill in the art. 
In some embodiments of the presently-disclosed methods 
for producing an epoxy fatty acid, Which make use of vectors 
that include nucleic acids of interest, the ?rst isolated nucleic 
acid and second isolated nucleic acid are each operatively 
linked to an expression cassette. In some embodiments, each 
expression cassette includes a seed-speci?c promoter or a 
constitutive promoter such that the expression of the nucleic 
acids can be directed to seed cells or canbe directed to express 
in all cell types of a host, to the extent it may be desired. 
In some embodiments of the presently-disclosed methods, 
the DGAT polypeptide that is expressed in a cell is a DGATl 
polypeptide. In some embodiments, the DGATl polypeptide 
is a DGATla polypeptide, such as a Vernonia galamensis 
DGATlapolypeptide (see, e. g., GENBANK® Accession No. 
5 
5 
20 
25 
30 
35 
40 
45 
50 
55 
60 
65 
14 
EF653276.1, Which is incorporated herein by this reference). 
In some embodiments, the DGATla polypeptide is encoded 
by a nucleic acid sequence of SEQ ID NO: 4. In some embodi 
ments, the DGATl polypeptide is a DGATlb polypeptide, 
such as a Vernonia galamensis DGATlb polypeptide (see, 
e.g., GENBANK® Accession No. EF653277, Which is incor 
porated herein by this reference). In some embodiments, the 
DGATlb polypeptide is encoded by a nucleic acid sequence 
ofSEQ ID NO: 17. 
In other embodiments, the DGAT polypeptide that is 
expressed in a cell is a DGAT2 polypeptide, such as a Ver 
nonia galamensis DGAT2 polypeptide (see, e.g., GEN 
BANK® Accession No. EJ652577, Which is incorporated 
herein by this reference). In some embodiments, the DGAT2 
polypeptide is encoded by a nucleic acid sequence of SEQ ID 
NO: 1. 
In some embodiments of the presently-disclosed methods, 
the epoxygenase polypeptide is encoded by a nucleic acid 
sequence of SEQ ID NO: 5. In some embodiments, the epoxy 
genase polypeptide is a Slokesia laevis polypeptide, such as 
the epoxygenase described in US. Pat. No. 7,364,901, Which 
is incorporated herein by this reference (see, also, GEN 
BANK® Accession No. EA619792.1, Which is further incor 
porated herein). 
The practice of the presently-disclosed subject matter can 
employ, unless otherWise indicated, conventional techniques 
of cell biology, cell culture, molecular biology, transgenic 
biology, microbiology, recombinant DNA, and immunology, 
Which are Within the skill of the art. Such techniques are 
explained fully in the literature. See, e. g., Molecular Cloning 
A Laboratory Manual (1989), 2nd Ed., ed. by Sambrook, 
Fritsch and Maniatis, eds., Cold Spring Harbor Laboratory 
Press, Chapters 16 and 17; US. Pat. No. 4,683,195; DNA 
Cloning, Volumes I and II, Glover, ed., 1985; Polynucleotide 
Synthesis, M. J. Gait, ed., 1984; Nucleic Acid Hybridization, 
D. Hames & S. J. Higgins, eds., 1984; Transcription and 
Translation, B. D. Hames & S. J. Higgins, eds., 1984; Culture 
Of Animal Cells, R. I. Freshney, Alan R. Liss, Inc., 1987; 
Immobilized Cells And Enzymes, IRL Press, 1986; Perbal 
(1984), A Practical Guide To Molecular Cloning; See Meth 
ods In Enzymology (Academic Press, Inc., NY); Gene 
TransferVectors For Mammalian Cells, J. H. Miller and M. P. 
Calos, eds., Cold Spring Harbor Laboratory, 1987; Methods 
In Enzymology, Vols. 154 and 155, Wu et al., eds., Academic 
Press Inc., N.Y.; Immunochemical Methods In Cell And 
Molecular Biology (Mayer and Walker, eds. , Academic Press, 
London, 1987; Handbook Of Experimental Immunology, 
Volumes I-IV, D. M. Weir and C. C. BlackWell, eds., 1986. 
The presently-disclosed subject matter is further illustrated 
by the folloWing speci?c but non-limiting examples. Some of 
the folloWing examples are prophetic, notWithstanding the 
numerical values, results and/or data referred to and con 
tained in the examples. 
EXAMPLES 
Example 1 
Cloning and Structural Analysis of a cDNA 
Encoding Diacylglycerol Acyltransferase 2 (DGAT2) 
from Vernonia galamensis 
First strand cDNAs made from total RNA from developing 
Vernonia galamensis seeds Were used for to clone the full 
length diacylglycerol acyltransferase 2 (DGAT2) cDNA 
(SEQ ID NO: 3). Brie?y, three pairs of degenerate primers 
Were designed and used to amplify partial sequences from 
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?rst-strand cDNAs derived from developing Vernonia seeds 
using loW-stringency polymerase chain reaction (PCR) pro 
tocols. After several rounds of degenerate PCR, three frag 
ments With different lengths Were ampli?ed. One amplicon 
(around 300 bp) Was con?rmed to share homology With 
knoWn DGAT2 sequences (e. g., 81% identity to Arabidopsis 
DGAT2) at the DNA sequence level. This partial sequence 
Was thenused to design the primers for isolation of full-length 
cDNA sequences by 5' and 3' RACE (rapid ampli?cation of 
cDNA ends). A full-length cDNA (designed as VgDGAT2; 
SEQ ID NO: 3) Was then obtained and sub-cloned into the 
pGEM-T Easy plasmid according to the manufacturer’s 
instructions, and the inserted cDNA Was sequenced in both 
directions. 
Database searches Were also performed using the BLAST 
program at the National Center of Biotechnology Informa 
tion. Alignments of the DNA or expected protein sequences 
Were performed With MegAlign of DNASTAR® (DNASTAR 
Inc., Madison, Wis.) and the protein motifs Were identi?ed 
using PROSITE scan and LocaliZome. 
The full-length VgDGAT2 cDNA that Was obtained by 5' 
and 3' RACE (SEQ ID NO: 3; GENBANK® BanKit No. 
1176836) Was found to be 1,212 bp in length and included 84 
bp of a 5'-leader sequence and 111 bp of a 3'-untranslated 
region. The open reading frame Was found to be 1, 017 bp in 
length (SEQ ID NO: 1) and Was found to encode a protein of 
338 amino acids (SEQ ID NO: 2). Alignment of the deduced 
amino acid sequences of DGAT2s from different species 
revealed that the proteins shared at least approximately 50% 
identity (FIGS. 1A and 1B). No homology Was found 
betWeen the VgDGAT2 amino acid sequence and the amino 
acid sequences of diacylglycerol acyltransferase 1 (DGAT1) 
peptides, including the DGAT1 sequences of Vernonia gala 
mensis (VgDGATl) and other species. A hydropathy plot of 
the VgDGAT2 amino acid sequence indicated thatVgDGAT2 
has tWo possible transmembrane regions located near the 
N-terminus of the sequence and in the region of amino acids 
36-52 and 57-84 (FIG. 1A). 
An alignment of multiple DGAT2 proteins Was also used to 
identify potential retrieval motifs (FIG. 1A), and revealed that 
the DGAT2 proteins contain a motif, Which is similar to a 
recently identi?ed pentapeptide ER retrieval motif (McCartt 
ney et al., 2004), and Was positioned at the extreme C-termi 
nus of the proteins. This ER motif Was found to be “-LELKI-” 
(SEQ ID NO: 6) in VgDGAT2. 
Example 2 
VgDGAT 1a and VgDGAT2 Gene Expression in 
Developing Vernonia Seeds 
To assess the gene expression of VgDGATla and VgD 
GAT2 in developing Vernonia galamensis seeds, primers for 
speci?c ampli?cation of each cDNA Were designed using 
Primer Express softWare (Applied Biosystems, Foster City, 
Calif.), taking into account criteria such as product length 
(around 500 bp), optimal PCR annealing temperature, and 
likelihood of primer self-annealing. The primers for speci?c 
ampli?cation of VgDGATla and VgDGAT2 cDNA Were 
designed to amplify the target cDNA at approximately 500 bp 
in length. The primers for VgDGATla Were 5'-CCACCA 
CAACTATAAGACGGCGGACCACTGT-3' (SEQ ID NO: 
7; forWard) and 5'-CTGAATCGAACCTCAGAATCAT 
GAAGACCGG-3' (SEQ ID NO: 8; reverse). The primers for 
VgDGAT2 Were 5'-CGAATCTTTAGTTATGTCAG 
TAAATACGTTA-3' (SEQ ID NO: 9; forward) and 5'-TAAT 
AGCCCTAGCCTTCAGTACGTAGAATTCG-3' (SEQ ID 
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NO: 10; reverse). The primers for the actin gene (internal 
standard) Were 5'-AGGGGATAACCACCCCAT 
GAATCCA-3' (SEQ ID NO: 11; forWard) and 5'-TGCATG 
GTCTCCTGATACGGCCAAG-3' (SEQ ID NO: 12; 
reverse). 
PCR reactions Were performed in triplicate in 25 pL vol 
umes using 1 pL of each forWard and reverse primer (500 
nM), 12.5 pL of SYBR® green master mix, 5 pL of a 1:10 
(v/v) dilution of cDNA and 5.5 pL of DEPC treated Water. 
Reactions Were performed in MicroAmp 96-Well plates (Ap 
plied Biosystems, Foster City, Calif.) covered With optical 
adhesive covers (Applied Biosystems, Foster City, Calif.). 
The folloWing program Was applied: initial polymerase acti 
vation at 950 C. for 10 min; then a tWo-temperature thermal 
cycle consisting of denaturation at 950 C. for 15 s, folloWed 
by annealing and extension at 600 C. for 1 min, With a total of 
40 cycles. 
To perform the PCR reactions, total RNA from roots, 
stems, leaves, pericarp, and developing seeds of Vernonia 
galamensis plants at six developmental stages (10, 17, 24, 31, 
38 and 45 days after pollination (DAP)) Was isolated, and then 
reverse transcribed to the ?rst strand cDNA using the methods 
described above. The ?rst-strand cDNA (5 uL) Was used to 
amplify the target cDNA. All real-time reactions Were per 
formed in an iCycler iQ detection system (Bio-Rad, Hercules, 
Calif.) using the intercalation dye SYBR® Green I master 
mix kit (Applied Biosystems, Foster City, Calif.) as a ?uo 
rescent reporter. PCR reactions Were performed in triplicate. 
The quanti?cation of PCR products Was performed via a 
calibration curve procedure using the actin gene as an internal 
standard. PCR products Were analyZed using melting curves 
as Well as agarose gel electrophoresis to ensure single product 
ampli?cation. The ratio of gene-speci?c expression to actin 
signal Was de?ned as relative expression. PCR controls Were 
performed in the absence of added reverse transcriptase to 
ensure RNA samples Were free of DNA contamination. 
Upon analysis of the results from these experiments, it Was 
observed that transcript levels of both VgDGATs Were much 
higher in embryos (sampled at 20 DAP) than in root, stems, 
leaves and pericarp Where their expressions Were not much 
different except for slightly higher levels in stem and leaf 
(FIG. 2A). VgDAGTla expression Was higher than VgD 
GAT2 in sampled organs. Tissue-speci?c expression analyses 
indicated that both VgDGATs may be important for Vernonia 
seed oil biosynthesis. 
During seed development, VgDGATla transcripts moder 
ately increased at early stages (from 10 to 17 DAP) and then 
sharply rose up to its peak level at 24 DAP (FIG. 2B). Sub 
sequently, VgDGATl a expression dropped gradually until 45 
DAP. Similarly, VgDGAT2 mRNAs elevated at the greatest 
rate betWeen 17 and 24 DAP and reached its highest level at 
31 DAP (later than VgDGATla), folloWed by a sloW decline 
from 31 to 38 DAP and then quickly decreasing. Compared to 
VgDGATl a, the expression level of VgDGAT2 Was higher at 
intermediate stages of development (betWeen 24 and 38 
DAP), a period during Which both vemolic acid and total seed 
oil accumulate to 70% of their maximum levels (FIG. 2C). 
Notably, the highest rate of vemolic acid and total oil increase 
Was betWeen 31 and 38 DAP, Which Was tWo stages later than 
the maximum level of both VgDGAT mRNAs Which Was 
from 17 to 24 DAP (FIGS. 2B and 2C). Collectively, these 
data thus indicate that both VgDGATs contribute to the pro 
duction of seed-speci?c triacylglycerols (TAGs) containing 
vemolic acid, With VgDGAT2 likely having a greater role. 
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Example 3 
Co-Expression of VgDGAT With SlEPX in 
Agro-In?ltrated Petunia Leaves 
To determine the effects of the co-expression of VgDGATs 
and Slokesia laevis epoxygenase genes (SlEPX) in agro-in 
?ltrated petunia leaves, the coding regions of SlEPX (SEQ ID 
NO: 5), VgDGATla (SEQ ID NO: 4), and VgDGAT2 (SEQ 
ID NO: 1) Were ampli?ed With gene-speci?c primers contain 
ing recombination cloning sites, digested accordingly, and 
subsequently inserted betWeen CaMV 35S promoter and 
NOS terminator in a modi?ed pBI121 vector (Clontech, Palo 
Alto, Calif.) according to established protocols (Chen, et al., 
2003). The recombinant binary pBI121 vector containing 
each of the target genes Was then electroporated into anAgro 
bacterium Zumefaciens cell strain GV3850 according the 
manufacturer’s protocol (BioRad Laboratories, Hercules, 
Calif). 
The folloWing agro-in?ltrations Were then performed as 
described previously (Wu, et al., 2005). Brie?y, petunia 
leaves for experimental in?ltration Were chosen on the basis 
of siZe With a 5-cm Width minimum. Leaves Were either left 
on plants or cut from plants and rinsed in tap Water to remove 
any adhering debris. Immediately prior to in?ltration, 
detached leaves Were placed on dampened paper toWels in 
plastic boxes on the lab bench. PositiveA. Zumefaciens clones 
carrying the expression vector Were maintained under kana 
mycin and rifampicin selection. Overnight cultures of single 
positive clones for in?ltration Were concentrated by brief 
centrifugation, and Were resuspended in a 10% sucrose solu 
tion to a ?nal concentration of OD6OO:0.5 (:005). The addi 
tion of 20 mM acetosyringone 3 h prior to in?ltration 
enhanced plant expression in some experiments, but Was not 
necessary. Petunia leaves Were subsequently nicked on the 
loWer leaf surface, and the bacterial suspension Was then 
introduced using a needle-less syringe. For SlEPX/ 
VgDGATla or SlEPX/VgDGAT2 co-expression in petunia 
leaves, the solution of A. Zumefaciens clones containing the 
SlEPX expression vector Was mixed 1 :1 With the VgDGATla 
or VgDGAT2 expression vector. These mixed solutions Were 
then used for in?ltration. 
During the experiments, the in?ltrated plants Were main 
tained in a greenhouse, While the detached petunia leaves of 
in?ltration Were maintained in an open plastic container on 
Wet paper toWels for up to 1 Week at room temperature. Zones 
of in?ltration Were harvested With a sterile cork borer at 5 or 
6 days after injection, and the resulting leaf discs Were stored 
at —70° C. Experiments Were repeated six times, and each 
gene construct Was evaluated on 3 to 5 plants (3 leaves of each 
plant). 
Without Wishing to be bound by any particular theory, it 
Was thought that if both VgDGATs function in the production 
of TAGs containing vernolic acid, co-expression of an epoxy 
genase gene, such as from Slokesia laevis (i.e., SlEPX), and 
either VgDGAT should lead to the enhancement of vernolic 
acid in the host tissues. To verify this, the agro-in?ltration 
approach described above Was used for in planta transient 
expression of eitherVgDGAT alone, or either VgDGAT com 
bined With SlEPX. 
In these experiments, RT-PCR ampli?cation of target 
cDNA from petunia leaf tissue agro -in?ltrated With the trans 
genes Was further used to assess the utility of this system for 
the generation of the expected transcripts (FIGS. 3A and 3B). 
Brie?y, total RNA of the agro-in?ltrated petunia leaf tissue 
Was isolated using a standard isolation procedure and 5 ug of 
RNA Was used for ?rst-strand cDNA synthesis With an oligo 
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(dT) primer. An aliquot of the ?rst-strand synthesis reaction 
Was then used in combination With transgene-speci?c prim 
ers. 
Using these RT-PCR procedures, the time course for petu 
nia mesophyll cells taking up and expressing the T-DNA 
borne transgenes folloWing agro-in?ltration Was ?rst deter 
mined in leaf discs collected at 2, 3, 5, 7 and 9 days after 
agro-in?ltration and tested for transgene expression by semi 
quantitative RT-PCR (FIG. 3A). The introduced genes Were 
expressed at loW levels for the ?rst 2 d after in?ltration, then 
increased dramatically over the next 3 days. The maximum 
expression of the introduced genes Was observed by 5 d post 
agro-in?ltration and declined thereafter. Further experiments 
also revealed that templateless control, RNA from unin?l 
trated and vector control in?ltrated leaves shoWed no ampli 
?cation product of the transgene, While the complete experi 
mental reaction yielded the product of the transgene the as 
same as in the positive control of plasmid DNA template 
(FIG. 3B), thus indicating that the target transgenes expressed 
correctly in this system. 
Based on the time course of the transgene expression, the 
agro-in?ltrated petunia leaf tissues Were then sampled at 5-6 
d post in?ltration for total lipid extraction and subsequently 
for thin layer chromatography (TLC) and gas chromatogra 
phy (GC) analysis. Brie?y, samples prepared as described 
above Were froZen in liquid N2, stored at —80° C. and then 
lyophiliZed. Weighed samples Were transferred to glass test 
tubes and tri-heptadecanoin (tri-17:0) Was then added at 10 
ug/mg tissue as a standard. The samples Were ?nely ground, 
and 1-2 mL of chloroform and methanol (2:1) containing 
0.001% butylated hydroxytoluene (BHT) Was added and 
samples ground further. After a brief spin, the loWer layer 
(CHCl3 phase) Was subsequently transferred into a neW glass 
tube. The samples Were then divided into tWo aliquots, and 
one Was used for TLC and the other directly for GC analysis. 
For GC analysis, samples Were then dried With N2, and 0.5 
mL of sodium methoxide (NaOCH3) Was then added and 
incubated for at least 15 minutes With shaking at 22° C. 0.5 
mL of isooctane containing 0.001% BHT Was added to each 
tube and mixed Well. Phase separation Was obtained With 
centrifugation or adding aqueous 0.9% KCl if needed. The 
top layer Was extracted and transferred into GC auto-sampler 
vials. The fatty acid methyl esters (FAMEs) Were analyZed 
With gas chromatography on a Varian CP-3800 GC With a 24 
m><0.25 mm ID CP-Select CB for FAME fused silica column 
With a 0.25 um ?lm thickness. The temperature program Was 
900 C. for 1 min, then to 155° C. at 20° C./min With no hold, 
then to 175° C. at 36° C./min With no hold and ?nally to 250° 
C. at 12° C./min holding for one min. 
For separation of individual lipid classes by TLC, the 
samples (CHCl3 lipid extracts) Were subsequently concen 
trated to about 50 to 100 uL. 10 pL of the sample Was loaded 
in a narroW band in lanes of silica gel 60 TLC plates 1 cm from 
the bottom of the plates. The plates Were put in a chamber 
With chloroform: methanol: Water (65:25:4, v/v)+0.0001% 
BHT for running until the ?rst solvent reached halfWay up the 
plate (approximately 10 cm). Then, the plate Was moved into 
the second solvent, hexanezdiethyl ether:acetic acid (100: 
100:2, v/v)+0.0001% BHT and developed until solvent Was 
approximately 1 cm from the top. After development, the 
plate Was dried, and subsequently sprayed With 0.005% 
primulin in 80% acetone, folloWed by visualiZing under UV 
light and marking the bands of interest. The bands Were 
scraped transferred to a Pasteur pipette With a glass Wool plug 
and Washed With CHCl3zCH3OH. The lipid samples Were 
eluted With 0.5 mL of CHCl3:CH3OH+0.0001% BHT tWice. 
Finally, eluted lipid samples Were dried, 0.5 mL sodium 
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methoxide added and fatty acid methyl esters Were prepared 
and analyzed by GC as described above. 
Hydroxy/methoxy and trimethyl-silyl derivatives of epoxy 
fatty acids Were also prepared as described previously (Ca 
hoon, et al., 2002) With 2.5% sulfuric acid in methanol and 
bis-(trimethylsilyl) tri?uoroacetamide: trimethylchlorosi 
lane (99: 1, v/v) (Supelco, Bellefonte, Pa.) With heating. GC 
MS analyses Were performed on an HP GCD GC-MS system 
With both HP-5 and Varian Factor Four VF-23MS capillary 
columns (30 m><0.25 mm, 0.25-p_m phase thickness). 1 uL 
samples Were injected in the splitless mode at 250° C. With an 
initial oven temperature of 100° C. for 1 min folloWed by a 
15° C./min gradient to 160° C. (Ramp 1) and a 4° C./min 
gradient to 240° C. (Ramp 2). Samples Were further analyZed 
using a Thermo Finnigan DSQ GC-MS system equipped With 
a Restec Rtx-5 (CROSSBOND® 5% diphenyl/ 95% dimethyl 
polysiloxane) capillary column (30 m><0.32 mm, 0.25-um 
phase thickness). 1.5 uL samples Were injected in the splitless 
mode at 250° C. With an initial oven temperature of 150° C. 
for 1 min folloWed by a 4° C./min gradient to 240° C. (Ramp 
1), a 20° C./min gradient to 300° C. (Ramp 2), and 5 minutes 
at 300° C. 
Upon analysis of the results from these experiments, it Was 
observed that vernolic acid Was not detected in the non-agro 
in?ltrated and empty-vector-control leaves, but Was present 
in the petunia leaves expressing epoxygenase alone and in 
petunia leaves co-expressing epoxygenase and either VgD 
GAT (FIG. 4A). Compared to the expression of SlEPX alone, 
VgDGATla co-expression increased vemolic acid level tWo 
fold, and VgDGAT2 co-expression resulted in an enhance 
ment of about ?ve times more. Others have previously 
reported that transgenic plants expressing epoxygenases that 
accumulate vernolic acid also shoW readily detectable levels 
of the epoxygenation product of ot-linolenic acid, 12-epoxy, 
Z9, Z15-octadecadienoic acid (12-epoxy-18:2A9,15) at lev 
els as much as a third or more of the vemolic acid levels 
(Singh, et al., 2001 and Cahoon, et al. 2002). HoWever, 
despite thorough analyses, little 12-epoxy-18:2A9,15 Was 
found in any of the high vernolic acid accumulating plant 
tissues. With careful selective ion scans of GC-MS runs, 
12-epoxy-18:2A9,15 Was found at approximately 0.1% of the 
vernolic acid levels or at less than or equal to 0.04% of total 
fatty acids. 
To further examine Whether the neWly synthesiZed vernolic 
acids Were in TAGs, TLC Was used to separate TAG from 
other lipid classes, and fatty acid pro?les in TAG Were ana 
lyZed by GC. From these experiments, it Was clear that ver 
nolic acid Was found in the leaves expressing SlEPX alone or 
With each VgDGAT While no vemolic acid Was detected in the 
control samples and leaves only expressing either 
VgDGATla or VgDGAT2 (FIG. 4B). Furthermore, it Was 
evident that vernolic acid accumulated to a much higher level 
in the VgDGAT2-co-expressing leaves than in the SlEPX 
only expressing samples or in the VgDGAT 1a-co-expressing 
samples. 
Experiments are also performed With agro-in?ltrated petu 
nia leaves co-expressing SlEPX andVgDGATlb. Similarly to 
the experiments described above, nucleic acid sequences 
including SlEPX and VgDGATlb (SEQ ID NO: 17) coding 
regions are inserted into a suitable plasmid and then elec 
troporated into an A grobaclerium Zumefaciens cell strain 
prior to agro-in?ltrating positive A. Zumefaciens clones into 
petunia leaves. Both nucleic acid sequences express correctly 
in the leaves and an increase in epoxy fatty acid accumulation, 
including levels of vernolic acid, is observed in the agro 
in?ltrated leaves, indicating that a method including express 
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ing a DGAT1b and an EPX transgene is useful in increasing 
an amount of epoxy fatty acid in a cell. 
Example 4 
Co-Expression of VgDGAT With SlEPX in Soybean 
Somatic Embryos 
To determine the effects of co-expression ofVgDGATs and 
SlEPX in soybean somatic embryos, an expression vector for 
soybean transformation Was constructed using the plant 
expression vector pCAMBIA1301, Which contained the 
hygromycin resistance gene as a selector and the GUS gene as 
a reporter (Cambia, ACT, Australia; GENBANK® Accession 
No. AF234297). The coding sequences of SlEPX, 
VgDGAT1a and VgDGAT2 Were ampli?ed by a high ?delity 
polymerase (Invitrogen, Carlsbad, Calif.) using end-speci?c 
primers containing restriction sites. The ampli?cation prod 
uct Was then sub-cloned into the respective sites of a 
pPHI4752 vector containing a phaseolin promoter, Which 
confers seed-speci?c expression of transgenes (see, Slightom 
et al., 1983). The phaseolin promoter cassette containing the 
coding region of each target gene Was then transferred into the 
corresponding sites of the binary pCAMBIA1301, T-DNA 
vector. These recombinant expression vectors Were subse 
quently introduced into somatic embryos of soybean (cv. 
‘Jack’) using the particle bombardment method of transfor 
mation. 
In this regard, soybean somatic embryo induction and cul 
ture Was carried out using a protocol modi?ed from prior 
procedures, (Collins et al., 1991; Finer and NagasaWa, 1988; 
Samoylov et al., 1998; Trick et al., 1997). Brie?y, immature 
soybean seeds at 3-5 mm length Were dissected, and cotyle 
dons Were placed on D40 solid medium for one-month induc 
tion. The induced embryos Were transferred to D20 plates for 
proliferation. The globular embryogenic cultures from D20 
plates Were then moved into FN liquid medium for one-month 
suspension culture. Small embryo clumps Were selected for 
shooting. 
Plasmid DNA/gold preparation for the particle bombard 
ment Was then conducted according to standard protocols 
(Trick et al., 1997). A DuPont Biolistic PDS1000/HE instru 
ment (helium retro?t) Was used for all transformations. After 
shooting, the embryo clumps Were transferred into FN liquid 
medium containing 30 mg/ L hygromycin for selective culture 
for four to ?ve Weeks. The positive transformed embryos 
obtained by hygromycin selection Were then moved into fresh 
FN liquid medium for culture and simultaneously for GUS 
test and identi?cation of the transgene presence by PCR (see, 
FIG. 5). The PCR-positive transgenic embryo lines Were then 
transferred into maturation medium (SHaM; Schmidt et al., 
2005) for three to ?ve Weeks. Matured individual embryos 
Were desiccated for 4-7 days, and then Were placed on half 
strength MS solid medium for germination. Germinated 
plantlets Were transferred to closed sterile soil cups for 
groWth in a culture room under 23:1 (light:dark) photoperiod 
cycle and 25° C. Once the seedlings reached a proper height 
(approximately 13 cm), they Were then transferred to a green 
house for ?owering and seed set under a 16:8 (light:dark) 
cycle, 25/21° C. 
For the transgenic lines, one set of matured somatic 
embryos Were sampled for lipid extraction and subsequent 
GC analysis. The rest of the matured somatic embryos Were 
desiccated, germinated and groWn to maturity in a green 
house. Mature seeds Were harvested from each regenerated 
soybean plant separately. Seeds Were chipped for genotyping 
by PCR and fatty acid analysis by GC. 














